Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 4 Grant or award Director acquired 65,430 shares (grant or award)
  2. 4 Grant or award Director acquired 65,430 shares (grant or award)
  3. 4 Grant or award Director acquired 65,430 shares (grant or award)
  4. 4 Grant or award Director acquired 65,430 shares (grant or award)
  5. 4 Open-market buy Director bought 33,785 shares at $0.89 ($30,190)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Shares withheld for taxes EVP, R&D and CMO gave up 50,103 shares (to pay taxes)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 34,148 shares (to pay taxes)
  10. 4 Grant or award Director acquired 37,735 shares (grant or award)
  11. 4 Grant or award Director acquired 37,735 shares (grant or award)
  12. 4 Grant or award Director acquired 37,735 shares (grant or award)
  13. 4 Grant or award Director acquired 37,735 shares (grant or award)
  14. 4 Grant or award Director acquired 37,735 shares (grant or award)
  15. 4 Grant or award Director acquired 37,735 shares (grant or award)
  16. 4 Grant or award Director acquired 37,735 shares (grant or award)
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 21,347 shares (to pay taxes)
  18. 4 Grant or award Director acquired 79,470 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy Director bought 55,525 shares at $1.80 ($99,945)

Page 4 of 33 · 648 filings